Abstract: A substrate for a printed circuit board includes a base film having an insulating property; a first conductive layer formed on at least one of surfaces of the base film by application of a conductive ink containing metal particles; and a second conductive layer formed, by plating, on a surface of the first conductive layer, the surface being on a side opposite to the base film, wherein a region near an interface between the base film and the first conductive layer contains a metal oxide species based on a metal of the metal particles and a metal hydroxide species based on the metal of the metal particles, the metal oxide species in the region near the interface between the base film and the first conductive layer has a mass per unit area of 0.1 ?g/cm2 or more and 10 ?g/cm2 or less, and a mass ratio of the metal oxide species to the metal hydroxide species is 0.1 or more.

Abstract: To provide a peptide which can be produced and processed more readily compared with prothymosin ? , which is conventionally known, or a peptide thereof and has an activity at a level equivalent to or higher than that of prothymosin ? or a peptide thereof. The present invention provides an ameliorating agent for blood-organ barrier dysfunction, a therapeutic agent for diseases associated with blood-organ barrier dysfunction or ischemic diseases or a nerve cell death inhibitor, each comprising, as an active ingredient, a peptide comprising the amino acid sequence represented by SEQ ID NO: 1 or a peptide having substantially the same function as that of the aforementioned peptide.

Abstract: A substrate for a printed circuit board according to the present invention includes a base film having an insulating property and including at least one opening; a first conductive layer that is formed on both surfaces of the base film by applying and heat-treating a conductive ink containing metal particles, and that fills the at least one opening; and a second conductive layer formed, by plating, on at least one of surfaces of the first conductive layer. The metal particles preferably have a mean particle size of 1 nm or more and 500 nm or less.

Abstract: A data selector circuit divides a group of data including a plurality of types of data into the plurality of types of data. A first compression circuit and a second compression circuit respectively compress the plurality of types of data in parallel with each other in accordance with each of the plurality of types of data. The first compression circuit compresses data and obtains compressed data. The second compression circuit compresses data and obtains compressed data. The data transmission circuit-transmits the compressed data and the compressed data to a terminal.

Abstract: The present invention aims to provide a novel compound for measuring cellular cytotoxicity or cell proliferation capacity accurately with high reproducibility, conveniently and rapidly, and a measurement method of cellular cytotoxicity or cell proliferation capacity by using the compound. The present invention relates to a compound represented by the formula (I): wherein R1 is a substituent, R2 and R3 are each an optionally substituted hydrocarbon group, or an optionally substituted heterocyclic group, Y is a substituent, n is an integer of 0-3, Z is a single bond, —O—, —S—, —SO—, —SO2—, or —NR4— (R4 is a hydrogen atom or a substituent), and A is an optionally substituted C1-6 alkylene group) or a salt thereof.

Abstract: A data processing system includes a plurality of data processing devices that perform in parallel data processing on the basis of initial setup data. The data processing devices each has a unique ID and includes a plurality of registers that store the initial setup data and a transfer circuit. The transfer circuit receives packets including a payload that is the initial setup data, shared information, a destination ID and a destination address and, when the shared information indicates that the payload is the initial setup data to be set commonly into the plurality of the data processing devices including its own data processing device, transfers the payload to the register that the destination address indicates irrespective of mismatching between the destination ID and its own ID.

Abstract: An object is to provide an immunoassay method requiring neither a solid-phase immobilization step nor a washing step, enabling quick and simple quantitative measurement of a target substance in a liquid phase and capable of visualizing an antigen.

Abstract: An antibody-fragment-immobilizing substrate includes a substrate and at least one set of antibody fragments, wherein the antibody fragments of each set includes at least two types of separate antibody fragments that are capable of recognizing one type of antigen and that are independently immobilized on the substrate in a positional relationship that allows each of the antibody fragments in one set to bind to the same antigen.

Abstract: A plurality of transfer modules (402-0 to 402-M) that transfer data between processing units are provided so as to respectively correspond to a plurality of processing units (401-0 to 401-M). First ring buses (403-0 to 403-M) connect, for each of the processing units (401-0 to 401-M), subunits within a corresponding processing unit and the transfer module corresponding to the processing unit so that they form a ring shape. The plurality of transfer modules (402-0 to 402-M) are connected so that they form a ring shape by a second ring bus (404).

Abstract: The present invention relates to solubility improving preparation for enhancing the oral absorption of a poorly soluble drug, which is comprising (A) and (B); (A) a granulated substance which comprises (i) a poorly soluble drug having an acidic group in the molecule, (ii) an alkaline agent, (iii) a surfactant, and this granulated substance dose not substantially contain a disintegrator, (B) a disintegrator existing only in the external of the granulated substance.

Abstract: In an image processing device, a motion image decoding processing unit extracts a feature amount of a target image to be decoded from an input stream, and changes a read size of a cache fill from an external memory to a cache memory, based on the feature amount. The feature amount represents an intra macro block ratio in, for example, one picture (frames or fields), or a motion vector variation. When the intra macro block ratio is high, the read size of the cache fill is decreased.

Abstract: An electrode of the invention for lithium ion secondary cells comprises a positive electrode current collector, a first positive electrode layer having a first binder made of a synthetic polymer having an ester bond and a first conductive agent and formed on the positive electrode current collector, and a second positive electrode layer having a positive electrode active substance, a second binder and a second conductive agent and formed on a surface of the first positive electrode layer opposite to the surface at which the positive electrode current collector is formed.

Abstract: A video encoding/decoding system includes a video encoding device and a video decoding device. The video encoding device includes an encoding part for encoding a diagnostic image or normal image. The video decoding device includes a decoding part for decoding the image encoded by the encoding part, a check signal generation part for generating a check signal of the decoded image, a storage part for storing the expected value of the check signal of the diagnostic image or the check signal generated by the check signal generation part, and a comparison part for comparing the check signal stored in the storage part with the check signal generated by the check signal generation part, in order to detect failure in all the paths from the image input part of the video encoding device to the image output part of the video decoding device.

Abstract: According to one embodiment, an electronic device includes a receiver, a transmitter, a management module, and an informing module. The receiver receives a purchase instruction from a user. The transmitter transmits the received purchase instruction to a server via a network. The management module manages a purchase history of the user. The informing module determines, upon receiving the purchase instruction from the user, whether the received purchase instruction satisfies a predetermined condition based on a purchase history of a predetermined period, and sends a message to the user if the purchase instruction satisfies the predetermined condition.

Abstract: The invention provides a method of treating chronic pain by administering an effective amount of a low-molecular weight compound that inhibits the enzyme activity of autotaxin to a subject in need thereof, thereby treating chronic pain in the subject. The chronic pain preferably is fibromyalgia, chronic fatigue syndrome, or hypersensitivity colitis.

Abstract: The present invention provides a non-human mammal deficient in the expression of prothymosin ? gene in the striatum and a screening method for a prophylactic/therapeutic drug for Huntington's disease and the like, which uses the animal.

Abstract: In a picture encoding device and a picture decoding device, the access to a reference frame memory is suppressed. The picture encoding device is comprised of a first encoder for intra picture encoding, a second encoder for inter picture encoding, and an intermediate buffer. A local decoded picture generated by the first encoder is stored as a reference picture in the intermediate buffer, and the inter picture encoding by the second encoder is performed by referring to the local decoded picture in the intermediate buffer. A picture decoding device is comprised of a first decoder for intra picture decoding, a second decoder for inter picture decoding, and an intermediate buffer. A local decoded picture generated by the first decoder is stored as a reference picture in the intermediate buffer, and the inter picture decoding by the second decoder is performed by referring the local decoded picture in the intermediate buffer.

Abstract: The present invention identifies a compound which binds to the PAH1 domain of mSin3B that specifically binds to neural restrictive silencer factor NRSF, and uses the compound as a prophylactic and/or a therapeutic for diseases associated with abnormal expression of neural restrictive silencer factor NRSF/REST or abnormal expression of genes targeted by NRSF/REST, such as Huntington's disease, medulloblastoma and neuropathic pain. The present invention provides a pharmaceutical composition comprising a substance capable of binding to the PAH1 domain of mSin3B, e.g.

Abstract: A digital camera of the present invention includes a receiving portion 155 that receives a control signal from a remote controller, and a microcomputer 110 having a live view mode controlling so that image data generated by a CMOS sensor 130 or image data obtained by subjecting the image data generated by the CMOS sensor 130 to predetermined processing is displayed on a liquid crystal monitor 150 as a moving image in real time, wherein when the receiving portion 155 receives the control signal from the remote controller, the microcomputer 110 controls so as to shift the digital camera to a live view mode. Due to this configuration, in a digital camera that includes a movable mirror and is capable of displaying a subject image in a live view through an electronic viewfinder, the operability thereof can be enhanced.

Abstract: To provide a peptide which can be produced and processed more readily compared with prothymosin ?, which is conventionally known, or a peptide thereof and has an activity at a level equivalent to or higher than that of prothymosin ? or a peptide thereof. The present invention provides an ameliorating agent for blood-organ barrier dysfunction, a therapeutic agent for diseases associated with blood-organ barrier dysfunction or ischemic diseases or a nerve cell death inhibitor, each comprising, as an active ingredient, a peptide comprising the amino acid sequence represented by SEQ ID NO: 1 or a peptide having substantially the same function as that of the aforementioned peptide.